Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Jazz Pharmaceuticals plc - Ordinary Shares
(NQ:
JAZZ
)
245.38
+4.90 (+2.04%)
Streaming Delayed Price
Updated: 11:34 AM EDT, Sep 11, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
115,852
Open
244.60
Bid (Size)
244.96 (200)
Ask (Size)
245.79 (100)
Prev. Close
240.48
Today's Range
244.17 - 246.57
52wk Range
123.88 - 266.38
Shares Outstanding
62,311,104
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Cash-Producing Stocks We’re Skeptical Of
Today 0:34 EDT
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...
Via
StockStory
Topics
Retirement
2 Reasons to Avoid JAZZ and 1 Stock to Buy Instead
Today 0:03 EDT
Jazz Pharmaceuticals’s 29.7% return over the past six months has outpaced the S&P 500 by 17%, and its stock price has climbed to $240.49 per share. This was ...
Via
StockStory
Topics
Stocks
Performance
YTD
+41.7%
+41.7%
1 Month
-1.1%
-1.1%
3 Month
+3.9%
+3.9%
6 Month
+36.1%
+36.1%
1 Year
+93.4%
+93.4%
More News
Read More
1 Value Stock with Exciting Potential and 2 We Brush Off
September 08, 2026
Via
StockStory
Topics
Energy
Retirement
Jazz Pharmaceuticals (NASDAQ:JAZZ): A Decent Value Stock Trading Below Its Worth
↗
September 02, 2026
Via
Chartmill
Stocks making big moves yesterday: Jazz Pharmaceuticals, SAIC, Herbalife, AGCO, and Deere
September 01, 2026
Via
StockStory
Cannabis Rally Turns Selective as Investors Reward Pharma-Tinged Names
↗
August 29, 2026
Via
Chartmill
Topics
Cannabis
Jazz Pharmaceuticals (NASDAQ:JAZZ): A Decent Value Opportunity
↗
August 12, 2026
Via
Chartmill
Jazz Pharmaceuticals (JAZZ) Stock Trades Up, Here Is Why
August 31, 2026
Via
StockStory
Topics
Artificial Intelligence
Jazz Pharmaceuticals Launches Ziihera After FDA Nod in HER2-Positive GEA
↗
August 25, 2026
Via
MarketBeat
Topics
Cannabis
3 Profitable Stocks with Questionable Fundamentals
August 14, 2026
Via
StockStory
Topics
Economy
Jazz Pharmaceuticals (JAZZ) Q2 2026 Earnings Call Transcript
↗
August 10, 2026
Via
The Motley Fool
Topics
Earnings
Cannabis Theme's Hidden Strength: Established Players Outshining Pure Plays
↗
July 30, 2026
Via
Chartmill
Topics
Cannabis
Cannabis Theme Rally Powered by Profitability, Not Pure-Play Speculation
↗
July 03, 2026
Via
Chartmill
Topics
Cannabis
5 Revealing Analyst Questions From Jazz Pharmaceuticals’s Q2 Earnings Call
August 10, 2026
Via
StockStory
Topics
Earnings
Jazz Pharmaceuticals Q2 Earnings Call Highlights
↗
August 03, 2026
Via
MarketBeat
Topics
Cannabis
Earnings
Jazz Pharmaceuticals (NASDAQ:JAZZ) Reports Bullish Q2 CY2026, Guides for Strong Full-Year Sales
August 03, 2026
Via
StockStory
Jazz Pharmaceuticals (JAZZ) Q2 Earnings: What To Expect
August 02, 2026
Via
StockStory
Topics
Artificial Intelligence
Cannabis Stocks Split into Two Camps: Profitable Operators vs. High-Growth Speculation
↗
June 18, 2026
Via
Chartmill
Topics
Cannabis
JAZZ PHARMACEUTICALS PLC (NASDAQ:JAZZ) Presents a Decent Value Opportunity with Strong Valuation and Growth Potential
↗
June 09, 2026
Via
Chartmill
3 Value Stocks with Open Questions
July 16, 2026
Via
StockStory
3 Overrated Stocks Walking a Fine Line
June 30, 2026
Via
StockStory
Jazz Pharmaceuticals' Lung Cancer Drug Setback in Late-Stage Trials: Here's Why the Stock Impact May Be More Limited Than It Looks
↗
June 23, 2026
Via
The Motley Fool
Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies
June 17, 2026
From
AbCellera Biologics Inc.
Via
Business Wire
Jazz Pharmaceuticals (JAZZ): Buy, Sell, or Hold Post Q1 Earnings?
June 15, 2026
Via
StockStory
Topics
Stocks
Pharmaceuticals Stocks Q1 Recap: Benchmarking Jazz Pharmaceuticals (NASDAQ:JAZZ)
June 14, 2026
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
Frequently Asked Questions
Is Jazz Pharmaceuticals plc - Ordinary Shares publicly traded?
Yes, Jazz Pharmaceuticals plc - Ordinary Shares is publicly traded.
What exchange does Jazz Pharmaceuticals plc - Ordinary Shares trade on?
Jazz Pharmaceuticals plc - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Jazz Pharmaceuticals plc - Ordinary Shares?
The ticker symbol for Jazz Pharmaceuticals plc - Ordinary Shares is JAZZ on the Nasdaq Stock Market
What is the current price of Jazz Pharmaceuticals plc - Ordinary Shares?
The current price of Jazz Pharmaceuticals plc - Ordinary Shares is 245.38
When was Jazz Pharmaceuticals plc - Ordinary Shares last traded?
The last trade of Jazz Pharmaceuticals plc - Ordinary Shares was at 09/11/26 11:34 AM ET
What is the market capitalization of Jazz Pharmaceuticals plc - Ordinary Shares?
The market capitalization of Jazz Pharmaceuticals plc - Ordinary Shares is 15.29B
How many shares of Jazz Pharmaceuticals plc - Ordinary Shares are outstanding?
Jazz Pharmaceuticals plc - Ordinary Shares has 15B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.